Chapter 30 Surgery of Intramedullary Tumors
INTRODUCTION
Intramedullary spinal cord tumors are rare, accounting for about 4–10% of all central nervous system tumors. Astrocytomas and ependymomas are the most commonly encountered spinal intramedullary tumors, and are found in up to 70% of all spinal intramedullary tumors. Most intramedullary cord tumors are benign gliomas. The determination of the optimum treatment of these tumors is controversial. In the past, there has been the traditional approach of biopsy, dural decompression, and radiation therapy, despite the recognition that after a relatively short remission, progression ensues, and the patient quickly becomes seriously disabled. This treatment was based on the assumption that astrocytomas are infiltrative tumors and that radical resection poses a high probability of inflicting neurological injury to the patient. These assumptions are debatable because most of these neoplasms are low-grade lesions. Recent advances in microsurgical technology, such as the ultrasonic aspirator, laser, intraoperative ultrasound, and intraoperative neurophysiological monitoring, permit a safer aggressive surgical resection. A radical surgical approach for intramedullary spinal cord tumor has been proposed by some surgeons. The radical resection without adjuvant treatment has been the rule for the intramedullary lesions.1 The postoperative functional performance is determined mainly by the preoperative deficits. The rate of aggravation is less than 20%. The most influencing prognostic factor for the postoperative result is the extent of tumor removal.2 The goal of surgery is maximal removal of the tumor mass without additional functional deficits.
SURGICAL TECHNIQUES OF INTRAMEDULLARY CORD TUMOR RESECTION
DURAL INCISION
A midline dural incision is made. Great care should be taken not to injure the arachnoid membrane. Under the microscope, the arachnoid membrane is sharply incised. The arachnoid membrane is tacked up by suturing it to the dura. Most tumors are totally intramedullary and are not apparent on surface inspection. An intraoperative ultrasound may be used to localize and determine the rostrocaudal tumor extent.3
IDENTIFICATION OF MIDLINE
There are two routes to intramedullary tumors: through the posterior midline or through a posterolateral myelotomy through the root entry zone.4 The former follows the posterior median sulcus, and the spinal cord is split between the two posterior columns.
The midline of the spinal cord is anatomically identified with branches of the dorsal medullary vein penetrating the median sulcus. The thin membrane from the arachnoid attaches to the dorsal midline surface of the spinal cord (area posticum). Sometimes a spinal cord edema makes it difficult to identify the midline on the posterior surface of the spinal cord. The vessels usually are located off midline and do not constitute reliable markers. If the anatomical midline is not definite, the imaginary line is assumed from the bilateral dorsal root entry zone. The tumor-infiltrated spinal cord possesses a swollen appearance.5 In cases of a hypervascular mass or tumor hemorrhage, the bluish discoloration is seen through the surface of the spinal cord6 (Fig. 30-1).
MYELOTOMY
The myelotomy can be performed with a No. 11 blade, a No. 59 beaver-blade, a CO2 laser, or a neodymium:yttrium-aluminum garnet (Nd-YAG) contact laser.4 Some surgeons routinely use the latter during myelotomy. Compared with electrocauterization, this technique causes no artifact during electrophysiological monitoring.
When the length of the myelotomy falls short, the resection margin cannot be identified. Discontinuous myelotomy is a viable technical option whenever the presence of large vessels on the median sulcus would make the standard midline myelotomy unsafe. After a small incision is made, the median sulcus is gently spread with the aid of microdissectors or microforceps to deepen the myelotomy until the tumor’s pole or cyst is exposed or opened both rostrally and caudally. The interface of the median sulcus usually can be identified by small vessels running over its surface, even if the midline has deviated to either side as a result of tumor compression (Fig. 30-2).
Fig. 30-2 At the interface of the median sulcus, the small vessels are penetrating into the pial surface.
The mass is encountered about 2 cm deep from the surface. The whole length of the mass is exposed, then the incision margin of the pia is sutured with a fine 6-0 or 7-0 nylon to the reflected dura. The spinal cord tissue over the tumor mass is retracted to expose the tumor mass (Fig. 30-3).
DISSECTION OF THE TUMOR MASS
Ependymoma
The gross appearance is soft, friable, red to gray, and not encapsulated. Usually ependymomas have a smooth, glistening tumor surface. However, they are well-demarcated from the surrounding cord tissue, being dissected with blunt manipulation. The rostral end of the ependymoma accompanies the cyst, but the caudal part of the mass sometimes is connected to the central canal with a tough, fibrous band (Fig. 30-4). Large tumors may require internal decompression with an ultrasonic aspirator. The dissection for the ventral surface of the tumor mass is difficult because the feeding artery from the anterior spinal artery is usually found. The feeding arteries should be cauterized and cut on the side of the tumor mass with the tumor mass tractioned posteriorly.